Dr. Revati Shreeniwas Joins ImmunoMet Therapeutics as Chief Medical Officer

Business Wire

Published

HOUSTON--(BUSINESS WIRE)--ImmunoMet Therapeutics today announced that Dr. Revati Shreeniwas has joined the company as Chief Medical Officer.

Full Article